Fisher Asset Management LLC decreased its position in Haleon plc (NYSE:HLN - Free Report) by 96.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 438,995 shares of the company's stock after selling 13,243,267 shares during the quarter. Fisher Asset Management LLC's holdings in Haleon were worth $4,188,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently bought and sold shares of the company. Procyon Advisors LLC lifted its position in Haleon by 41.3% in the 4th quarter. Procyon Advisors LLC now owns 230,240 shares of the company's stock worth $2,196,000 after buying an additional 67,329 shares during the last quarter. HighTower Advisors LLC lifted its position in Haleon by 27.2% in the third quarter. HighTower Advisors LLC now owns 350,795 shares of the company's stock valued at $3,701,000 after purchasing an additional 74,970 shares during the last quarter. Jane Street Group LLC lifted its position in Haleon by 1,689.4% in the third quarter. Jane Street Group LLC now owns 264,977 shares of the company's stock valued at $2,803,000 after purchasing an additional 250,169 shares during the last quarter. Chartwell Investment Partners LLC lifted its position in Haleon by 107.8% in the third quarter. Chartwell Investment Partners LLC now owns 475,415 shares of the company's stock valued at $5,030,000 after purchasing an additional 246,594 shares during the last quarter. Finally, Townsquare Capital LLC lifted its position in Haleon by 29.8% in the third quarter. Townsquare Capital LLC now owns 475,618 shares of the company's stock valued at $5,032,000 after purchasing an additional 109,217 shares during the last quarter. Institutional investors own 6.67% of the company's stock.
Wall Street Analyst Weigh In
Several analysts have weighed in on HLN shares. Morgan Stanley downgraded Haleon from an "overweight" rating to an "equal weight" rating in a research report on Friday, January 10th. Hsbc Global Res downgraded Haleon from a "strong-buy" rating to a "hold" rating in a research report on Wednesday. Sanford C. Bernstein downgraded Haleon from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 8th. Finally, HSBC reiterated a "hold" rating on shares of Haleon in a research report on Wednesday. Five analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Haleon has an average rating of "Moderate Buy" and a consensus price target of $10.95.
Check Out Our Latest Stock Analysis on HLN
Haleon Trading Up 0.5 %
Shares of HLN traded up $0.06 during mid-day trading on Friday, hitting $10.45. 10,381,006 shares of the company's stock traded hands, compared to its average volume of 6,535,003. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. Haleon plc has a 1 year low of $7.89 and a 1 year high of $10.80. The firm has a market capitalization of $47.29 billion, a P/E ratio of 30.72, a PEG ratio of 2.82 and a beta of 0.25. The business's 50-day moving average price is $9.66 and its 200-day moving average price is $9.86.
Haleon (NYSE:HLN - Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The firm had revenue of $3.54 billion for the quarter, compared to analysts' expectations of $3.38 billion. As a group, sell-side analysts forecast that Haleon plc will post 0.43 EPS for the current fiscal year.
Haleon Increases Dividend
The company also recently declared a -- dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be paid a $0.1166 dividend. This represents a yield of 1.6%. This is a boost from Haleon's previous -- dividend of $0.05. The ex-dividend date is Friday, April 25th. Haleon's dividend payout ratio is presently 58.97%.
Haleon Profile
(
Free Report)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Further Reading
Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
